(CMV) disease [3, 5] . However, not all patients with these risk factors develop invasive mold infections (IMIs), while some patients without these risk factors do, making it difficult to predict the individual-level risk of developing IMI.
Over the last decade, a series of studies have identified common genetic polymorphisms that are associated with the development of invasive aspergillosis among hematopoietic stem cell transplant recipients and other patients with oncohematological conditions [6, 7] . The identification of specific genetic variants may improve individual risk stratification and allow the development of personalized management strategies, as well as the use of prophylaxis or specific surveillance in individuals at high risk to develop invasive aspergillosis [6] . To date, no studies examined the role of such genetic polymorphisms on the susceptibility to fungal infections among SOT recipients. To our knowledge, this study is the first to explore the role of host genetics in susceptibility to IMI in SOT recipients.
MATERIALS AND METHODS

Patients and Study Design
The Swiss Transplant Cohort Study (STCS) is a large, nationwide, well-documented prospective cohort including all SOT recipients followed at 6 Swiss university transplantation centers (Basel, Bern, Geneva, Lausanne, St. Gallen, and Zurich) since May 2008 [8] . Patient data were systematically collected on standardized case report forms at enrollment, 6 months after transplantation, and every 12 months after transplantation.
Infectious complications were systematically evaluated by an infectious diseases specialist on the basis of clinical, histological, radiological, and mycological evidence and reported on a separate case report form. Medical records for patients reported to have fungal colonization or IMI were revised by an independent investigator (T. L.) [9] . Proven or probable IMI was defined on the basis of standardized European Organisation for Research and Treatment of Cancer/Mycoses Study Group guidelines and definitions [10] and adapted International Society for Heart and Lung Transplantation guidelines and definitions unique for lung transplant recipients, such as anastomotic bronchial infections or tracheobronchitis [11] . Colonization was defined by microscopic or culture detection of a mold from a specimen from a nonsterile site, including sputum, bronchoalveolar lavage, bronchial brush, sinus aspirate, or urine samples, in the absence of clinical signs/symptoms for infection. Patients who received a diagnosis of mold colonization and/or IMI before transplantation and/or who previously received an organ transplant were excluded. CMV infection was classified as asymptomatic replication, viral syndrome, or probable and proven disease as previously reported [12] .
Ethics Statement
All patients provided a written informed consent for participation in the STCS (including genetic analyses). The protocol was approved by the independent ethics committees of each Swiss participating center (University Hospital of Lausanne; University Hospitals of Geneva; University Hospital Zürich; Cantonal Hospital St. Gallen; Inselspital, Bern University Hospital; Clinica Luganese, Lugano; and University Hospital of Basel).
Fresh venous blood specimens were collected for functional studies from healthy volunteers who provided a written informed consent. The protocol was approved by the local ethics committee (Radboud University Nijmegen Medical Center, the Netherlands).
Peripheral Blood Mononuclear Cell (PBMC) Isolation and In Vitro-Stimulation Assays
PBMCs were isolated using Ficoll-Paque Plus density gradient centrifugation (GE Healthcare, Zeist, the Netherlands) as described previously [13] . Cells were subsequently stimulated with 1 × 10 7 live or heat-inactivated Aspergillus fumigatus conidia per milliliter for 24 hours or 7 days, respectively. Afterward, concentrations of the cytokines tumor necrosis factor α (TNF-α), interleukin 1β (IL-1β), interleukin 1 receptor antagonist (IL-1Ra), interleukin 17 (IL-17), interleukin 2 (IL-22; all from R&D Systems, Minneapolis Minnesota) and interferon γ (IFN-γ; Sanquin, Amsterdam, the Netherlands) were measured in cell supernatants by enzyme-linked immunosorbent assays according to the manufacturer's protocol.
Genotyping
A total of 24 single-nucleotide polymorphisms (SNPs) in 21 genes were selected from the literature by performing a PubMed search until June 2012, using the keywords "candidemia", "candidiasis", "aspergillosis", and "SNP" and by searching previous reviews on fungal immunogenetics [6, 7] . Blood samples were obtained from all SOT recipients at the time of transplantation. Genomic DNA was extracted from blood specimens obtained from patients or healthy volunteers and stored in ethylenediaminetetraacetic acid-containing tubes, using the Gentra Puregene Blood Kit (Qiagen). Genotyping was performed using a customized GoldenGate Genotyping Assay on Veracode platform (Illumina, San Diego, California), unless otherwise indicated. Results were analyzed on a BeadXpress Reader according to standard protocols and quality controls. Additional SNPs were genotyped using the Competitive Allele-Specific PCR system (LGC Genomics, Herts, United Kingdom). For functional studies, genotyping of the IL1B rs16944 and IL1RN rs419598 variants was performed on the ABI-Prism StepOne thermocycler (Applied Biosystems), using predesigned SNP assays.
Statistical Analysis
Statistical analyses were performed in Stata13 (StataCorp, College Station, Texas), unless otherwise indicated. The cumulative incidence of mold colonization and IMI by genetic variants at 36 months after the first transplantation was assessed by the log-rank test, with censoring at the date of the last follow-up visit or death. Associated variants were selected on the basis of log-rank test results and were further tested by univariate and multivariate Cox models. To estimate the independent contribution of each polymorphism to the end points, demographic and clinical factors previously associated with mold colonization and/or IMI, as described elsewhere [5, 9] , were entered into multivariate stepwise regression models (P < .2), together with relevant genetic polymorphisms. Haplotypes were inferred using PHASE 2.1 (University of Washington, Seattle). The power calculation for Cox proportional hazard regression analysis was done using an R implementation of the power and sample size calculation for survival analysis of epidemiological studies ( powerSurvEpi R package 0.0.6) [14] . The effect of the presence of SNPs on the Aspergillus-induced cytokine levels was determined by the Mann-Whitney U test. The data are presented as mean values ± standard error of the mean and were analyzed using GraphPad Prism v5.0 (San Diego, California).
RESULTS
Cohort Study
The . Factors significantly associated with IMI were identified and described elsewhere [9] and included in the multivariate analysis.
Genetic Risk Factors for Mold Colonization and IMI in SOT Recipients
The minor allele frequency of the 24 SNPs are shown in Table 2 . Three SNPs that deviated from Hardy-Weinberg equilibrium were excluded from the analyses. The power to detect mold colonization and IMI was calculated for each SNP (Table 4) . To assess the risk of fungal disease according to the different SNPs, we estimated their associations with colonization and infection during the first 36 months after transplantation ( Table 2) . Mold colonization and IMI were both associated with SNPs in 3 different genes, including the genes encoding IL-1β (IL1B; rs16944; TT vs CT or CC; P = .001 and P = .00005, c Including kidney and pancreas (n = 24), kidney and liver (n = 10), kidney and kidney (n = 5), kidney and islets (n = 3), two kidneys and pancreas (n = 2), kindey and lung (n = 1 respectively), β-defensin 1 (DEFB1; rs1800972; CC vs GG or CG; P = .001 and P = .0002, respectively), and IL-1Ra (IL1RN; rs419598; CC vs CT or TT; P = .01 and P = .02, respectively; Figure 1 ). In addition, we observed a significant association between a SNP in the gene encoding surfactant-associated protein 2 (SFTPA2; rs17886395; GG vs CC or CG) and mold colonization (P = .004) but not infection (P = .5). However, the number of cases carrying this polymorphism was very small (Supplementary Figure 4) . To determine whether the SNPs were independent risk factors for mold colonization and IMI, we used multivariate Cox stepwise regression models, after adjustment for all relevant covariates ( Figure 1 ). To account for a possible confounding role of antifungal prophylaxis, the analyses were repeated after removal of patients who received antimold b By the log-rank test, recessive mode (patients homozygous for the rare alleles are compared to the other patients). Five patients who were colonized with mold before transplantation, of whom 2 also developed IMI before transplantation, were removed from the analyses. c Significant after Bonferroni correction for multiple testing (21 tests; P = .02).
d Significant after Bonferroni correction for multiple testing (21 tests; P = .001).
e Significant after Bonferroni correction for multiple testing (21 tests; P = .004).
prophylaxis. The associations between the SNPs in IL1B, DEFB1, and IL1RN were still significant on repeat analysis (not shown).
IL1B rs16944 and IL1RN rs419598 Risk Haplotype for Mold Colonization and IMI
IL1B and IL1RN are located within an approximately 400 kb region on chromosome 2q13-21. We therefore analyzed whether haplotypic combinations of IL1B rs16944 and IL1RN rs419598 SNPs further influenced mold colonization and IMI ( Figure 2) . Carriage of the rs16944-rs419598 C-T haplotype was associated with a decreased risk of both mold colonization and IMI (C-T haplotype vs all others: HR, 0.34 [95% CI, .18-.63; P = .0007] and 0.21 [95% CI, .10-.45; P = .00008], respectively). Conversely, carriage of the T-C haplotype was associated with an increased risk for both phenotypes (T-C haplotype vs all others: Figure 1 . Cumulative incidence of mold colonization (n = 45) and invasive mold infection (IMI; n = 26), according to polymorphisms in genes encoding interleukin 1β (IL1B; rs16944; A and B, respectively), β-defensin 1 (DEFB1; rs1800972; C and D, respectively), and interleukin 1 receptor antagonist (IL1RN; rs419598; E and F, respectively), in solid-organ transplant recipients. Patients with mold colonization or IMI before engraftment were excluded from the analyses. P values were calculated by the log-rank test, recessive mode ( patients homozygous for the rate alleles are compared to the other patients). For the IL1B rs16944 and DEFB1 rs1800972 single-nucleotide polymorphisms, P values remained significant after correction for multiple testing (21 tests; IL1B rs16944, colonization P = .02, IMI P = .001; and DEFB1 rs1800972, colonization P = .02, IMI P = .004). The total number of patients in the multivariate analysis (n = 1047) was slightly lower than in the univariate analysis (n = 1101), owing to missing covariates. Five patients who were colonized with mold before transplantation, of whom 2 also developed IMI before transplantation, were removed from the analyses. 
Figure 2. Cumulative incidence of mold colonization (A and B) and invasive mold infection (IMI; C and D) according to rs16944-rs419598 C-T (A and C)
or T-C (B and D) haplotypes of polymorphisms in the genes encoding interleukin 1β (IL-1β) and interleukin 1 receptor antagonist (IL1-Ra) among solid-organ transplant recipients. P values were calculated by the log-rank test by using the dominant mode of inheritance (patients carrying 1 or 2 copies of each haplotype are compared to the other patients). Patients with mold colonization or IMI before engraftment were excluded from the analyses.
HR, 1.83 [95% CI, 1.02-3.29; P = .04] and 2.09 [95% CI, .97-4.50; P = .06], respectively).
Effect of IL1B rs16944 and IL1RN rs419598 SNPs on AspergillusInduced Cytokine Release
To determine whether the SNPs associated with IMI and colonization had measurable biological effects, we analyzed the production of different cytokines that are involved in antifungal host defense, including IL-1β, IL-1Ra, TNF-α, IL-17, IL-22, and IFN-γ in PBMCs from 73 healthy volunteers, after stimulation with live or heat-inactivated A. fumigatus conidia (Figure 3) . PBMCs from volunteers carrying the IL1B rs16944 TT genotype produced lower amounts of IL-1β (P = .01), TNF-α (P = .03), and IL-22 (P = .03) after stimulation with A. fumigatus, compared with PBMCs from volunteers carrying the TC and CC genotypes. However, the production of IL-1Ra, IL-17, and IFN-γ was not significantly influenced by IL1B rs16944.
PBMCs from volunteers carrying the IL1RN rs419598 CC genotype produced lower amounts of IL-1β (P = .03) and TNF-α (P = .04) after stimulation with A. fumigatus, compared with PBMCs from volunteers carrying the TC and TT genotypes. However, the production of IL-1Ra itself, as well as IL-22, IL-17 and IFN-γ, was not influenced by IL1RN rs419598.
DISCUSSION
While a number of investigators have reported associations between genetic polymorphisms and susceptibility to invasive aspergillosis among patients with onco-hematological conditions [6, 7] , the role of such polymorphisms has not been studied among SOT recipients. We are the first to report an association between polymorphisms in IL1B, its antagonist IL1RN, and DEFB1 on the susceptibility to IMI in this population. The IL1B gene encodes the cytokine IL-1β, which is essential in host defense against Aspergillus infection [15] . IL-1β is a potent proinflammatory cytokine that recruits neutrophils, which are crucial for clearing Aspergillus [16] , to the lungs during infection. Resting Aspergillus conidia in the respiratory epithelium are detected by alveolar macrophages and/or dendritic cells (DCs). These cells express a wide variety of pattern-recognition receptors (PRRs) [17] that detect molecular patterns from the fungal cell wall (eg, o-linked mannan, galactomannan, and β-[1-3]-glucan) [7] . Whereas macrophages produce TNF-α and IL-1β upon recognizing Aspergillus, resulting in the recruitment of neutrophils and monocytes, activated DCs will migrate to lymph nodes to induce protective T-helper cell activity. IL-1β induces T-helper type 17 (Th17) responses that are characterized by the production of IL-17, leading to increased recruitment of neutrophils. Additionally, the activated T-helper cells induce IL-22 responses that will stimulate production of defensins by epithelial cells [7, 13] . Thus, IL-1β is a key player in the induction of protective innate and adaptive anti-Aspergillus host defense.
Because of its potent inflammatory capacity, the IL-1β response must be tightly controlled. This is underlined by the observation that patients with a mutation in IL-1Ra have severe inflammation of the skin and bones because of uncontrolled neutrophil influx and increased Th17 responses [18] . Moreover IL-1Ra knockout mice were shown to be fully protected from developing invasive aspergillosis [19] . Importantly, galactosaminogalactan, an antiinflammatory cell wall component of A. fumigatus, was able to induce IL-1Ra in vivo and consequently suppress the IL-1β pathway, leading to increased susceptibility to invasive aspergillosis [19] . IL-1β binds to the IL-1 receptor, and this results in the recruitment of a second receptor (IL1RacP) [20] that activates signaling transduction pathways, thereby exerting potent inflammatory activities. IL-1Ra also binds to the IL-1 receptor but prevents recruitment of the second receptor and thus does not activate signal transduction pathways [20] . Therefore, the bioactivity of IL-1β is controlled by IL-1Ra [21] .
The polymorphisms associated with mold colonization and IMI in this study are located within the IL-1 cluster, located in chromosome 2, encompassing both IL1B and IL1RN. We found that the minor alleles of rs16944 and rs1143627 within IL1B were associated with an increased risk of mold colonization and IMI in SOT recipients. Consistent with our observation, the minor allele of rs16944 tended to be associated with an increased risk of invasive pulmonary aspergillosis in a case-control study of 110 neutropenic patients with hematological malignancies [22] . The minor alleles of these SNPs were also associated with susceptibility to different bacterial and viral infections. Two studies showed an association between rs16944 and/or rs1143627 and mortality due to meningococcal disease [23] . Studies among Chinese patients also showed an association between both SNPs and susceptibility to sepsis after major trauma [24] and 2009 pandemic influenza A(H1N1) virus [25] .
It has been previously shown that rs16944, located at position −511, which corresponds to a putative AP-2 binding site, and rs1143627, located at position −31 within the TATA box, are functional polymorphisms that could be responsible for alteration of promoter activity and thus be able to modulate expression and secretion of IL-1β in vitro [26] . In our study, PBMCs from individuals carrying 2 copies of a rare allele of IL1B rs16944 had diminished IL-1β release upon Aspergillus stimulation. In line with our data, human monocytes from individuals carrying the minor allele of rs1143627 had moderated transcriptional activity of IL1B promoter in response to lipopolysaccharide (LPS) [26] . Moreover, carriers of minor alleles of rs16944 or rs1143627 had significantly lower IL-1β levels in LPSinduced PBMCs [27] . However, other studies have reported that the minor allele of rs16944 was correlated with increased transcriptional activity of the promoter in vitro upon LPS stimulation and high IL-1β secretion [28, 29] . There is no clear IL1RN; rs419598; B) . PBMCs from 73 healthy volunteers with different IL1B rs16944 or IL1RN rs419598 genotypes were stimulated either with live Aspergillus fumigatus conidia for 24 hours (for TNF-α, IL-1β, and IL-1Ra) or heat-inactivated A. fumigatus conidia for 7 days (for IL-17, IL-22, and IFN-γ). The cytokine levels were measured in cell culture supernatants. Differences in the effects of SNPs on cytokine levels were calculated by the Mann-Whitney U test. The data are presented as mean ± standard error of the mean (SEM). explanation for these discrepant observations, but they may be due, at least in part, to the use of different cells or tissues; the use of different stimuli, stimulating concentrations, or durations; and/or the failure to account for other, so far unknown, regulating factors. We found that the IL1B rs16944 polymorphism was not only associated with less IL-1β production, but also with reduced TNF-α production in response to Aspergillus. TNF-α is another essential cytokine in antifungal host defense, and anti-TNF treatment has previously been associated with invasive aspergillosis [24, 30] .
The IL1RN rs419598 SNP, which is in strong linkage disequilibrium with the IL1RN variable number tandem repeat (VNTR) sequence, has also been associated with mold colonization and IMI [31] . Consistent with this finding, the minor allele of rs419598 was previously associated with severity of meningococcal disease and genital human papillomavirus clearance [23, 32] . To our knowledge, the functional role of rs419598 has not been explored so far. In the present study, the minor allele of rs419598 did not influence IL-1Ra production in PBMCs from volunteers stimulated with A. fumigatus. However, rs419598 carriers had significantly lower levels of IL-1β and TNF-α. This is consistent with a previous study, in which VNTR*2 was associated with decreased IL-1β production in the gastric mucosa, as well as in PBMCs stimulated with LPS [28, 33] . Together, these data suggest that IL1RN participates in the regulation of Aspergillus-mediated cytokine production and that IL1RN polymorphisms may reduce the ability to clear the pathogen. DEFB1 encodes human β-defensin 1, a member of the defensin family. Defensins are encoded by a polymorphic gene cluster located within a 450-kb region on chromosome 8p23 [34] . They exert antimicrobial activity against a broad spectrum of pathogens; they also exert chemotactic activity on immune cells and are able to induce cytokine production [35, 36] . β-defensin 1 is constitutively expressed in lung epithelial cells and was shown to exert antimicrobial properties against Candida albicans [37] . To our knowledge, the antimicrobial properties of this β-defensin against other fungal pathogens have not been investigated.
The minor allele of the rs1800972 SNP in DEFB1 was associated with an increased risk of mold colonization and IMI in SOT recipients. In line with our findings, the same allele was previously associated with higher-level oral Candida carriage among diabetic and nondiabetic patients [38] . The rs1800972 SNP is located at position −44 from the 5′ untranslated region of DEFB1 and was predicted to alter a putative transcription factor binding site to this region of the gene [39, 40] . The minor allele of rs1800972 has been previously associated with lower β-defensin 1 expression in the skin with increased nasal carriage of Staphylococcus aureus [41] . This allele may also decrease the expression of β-defensin 1 in the respiratory epithelium, with reduced ability to clear opportunistic pathogens such as mold under certain immunosuppressive conditions. Interestingly, the cytokine IL-22 is a potent inducer of defensins produced by epithelial cells [42, 43] . The IL1B rs16944 SNP was associated with a significant reduction in Aspergillus-induced IL-22 production in human PBMCs. Therefore, it can be proposed that this SNP may increase susceptibility, not only because of the low production of essential innate immune system cytokines such as IL-1β and TNF-α, but also because of a reduced induction of IL-22 that might result in defective induction of defensins.
SFTPA2 encodes pulmonary surfactant-associated protein 2 (SP-A2), a member of the collagen-containing soluble C-type lectin receptors (collectins). SP-A2 was shown to play an important role in host response to Aspergillus by its ability to bind A. fumigatus conidia and thus enhance phagocytosis by neutrophils and macrophages [44] . Polymorphisms in the collagen region of SFTPA2 (G1649C and/or A1660G) have been associated with chronic cavitary pulmonary aspergillosis [45] and allergic bronchopulmonary aspergillosis in asthmatic patients [46] . Here, we detected association between a G1649C polymorphism and mold colonization but not invasive mold infection in SOT recipients. The lack of association with infection may be due to insufficient statistical power due to the relatively small SNP allele frequency and sample size, as detailed in Table 4 .
By using 24 polymorphisms from 21 genes previously associated with susceptibility to fungal infections, we showed that SNPs from 3 genes (IL1B, IL1RN, and DEFB1) were associated with mold colonization or IMI in white SOT recipients. Mold colonization may have been underestimated, as bronchoscopy is not routinely performed, especially in nonthoracic SOT recipients. Yet, the polymorphisms associated with colonization were also associated with IMI, suggesting that these polymorphisms influence both phenotypes, with a continuum from colonization to invasive infection. We were not able to detect an association with polymorphisms in other genes, such as TLR4 or CLEC7A (which encodes dectin 1), that were previously reported to be associated with invasive aspergillosis by several investigators [6, 7] . This may be due to several factors, such as the inclusion of different study populations, fungal pathogens, and/or less invasive forms of infections. Importantly, the number of patients with mold colonization and/or IMI was small, leading to limited statistical power, especially for infrequent SNPs, as detailed in Table 4 . Larger studies and studies in patients who are not white will be needed to replicate such associations.
We report an association between polymorphisms in 3 genes and mold colonization and IMI in a nationwide cohort of SOT recipients. Theses associations were found to be independent from previously known risk factors, such as recipient age and CMV coinfection [3] . The genes were formerly described as important components of immune defenses against fungal pathogens, and the associated polymorphisms were all shown to be functionally relevant. Together, these findings may contribute to a better understanding of the pathogenesis of IMI in SOT recipients and help in individual risk stratification in the future. 
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